Table 2. Comparison of different BT alternatives in LC treatment.
| Characteristics | BT type | ||
|---|---|---|---|
| LDRIB | PDR | HDRIB | |
| Dose activity (Gy/h) | 0.4–2 | 2–12 | >12 |
| Indications | Tumours T1–T2. Positive surgical margins Post-surgical relapse. |
Tumours T1–T3. Positive surgical margins Post-surgical relapse. |
Tumours T1–T2, T4 (low-volume) Positive surgical margins Post-surgical relapse. |
| Contraindications | Bone infiltration | Bone infiltration | Bone infiltration |
| Local control (%) in 5 years | 94%–96.6% | 95% | >95% |